BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Markovics A, Angyal Á, Tóth KF, Ádám D, Pénzes Z, Magi J, Pór Á, Kovács I, Törőcsik D, Zouboulis CC, Bíró T, Oláh A. GPR119 Is a Potent Regulator of Human Sebocyte Biology. J Invest Dermatol 2020;140:1909-1918.e8. [PMID: 32142797 DOI: 10.1016/j.jid.2020.02.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Calvillo-Robledo A, Cervantes-Villagrana RD, Morales P, Marichal-Cancino BA. The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling. Life Sci 2022;:120596. [PMID: 35500681 DOI: 10.1016/j.lfs.2022.120596] [Reference Citation Analysis]
2 Manaithiya A, Alam O, Sharma V, Javed Naim M, Mittal S, Khan IA. GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus. Bioorg Chem 2021;113:104998. [PMID: 34048996 DOI: 10.1016/j.bioorg.2021.104998] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Im DS. GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide. Int J Mol Sci 2021;22:1034. [PMID: 33494185 DOI: 10.3390/ijms22031034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]